We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Determination of Adipocyte Parameters in Iliac Crest Biopsies From Post Menopausal Women

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00443716
First Posted: March 6, 2007
Last Update Posted: January 15, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Mayo Clinic
March 5, 2007
March 6, 2007
January 15, 2010
April 1985
April 1989   (Final data collection date for primary outcome measure)
efficacy of estraderm treatment on osteoporotic women
Same as current
Complete list of historical versions of study NCT00443716 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Determination of Adipocyte Parameters in Iliac Crest Biopsies From Post Menopausal Women
Determination of Adipocyte Parameters in Iliac Crest Biopsies From Post Menopausal Women
To evaluate the effect of estrogen treatment on adipocytic and osteoblastic parameters by histomorphometrically measuring adipocyte volume (AV/TV) and adipocyte numbers in goldner's stained iliac crest bone biopsy specimens collected from subjects recruited in the study (IRB number 21B85). The adipocytic parameters will be then correlated with osteoblastic parameters obtained previously during the course of the initai study involving the effect of transdermal estrogen on bone turnover in postmenopausal osteoporotic women.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
  • Osteoporosis
  • Postmenopausal
Drug: estrogen
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
60
April 1989
April 1989   (Final data collection date for primary outcome measure)
Post-menopausal osteoporotic women
Sexes Eligible for Study: Female
30 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00443716
05-004111
21b85
Yes
Not Provided
Not Provided
Not Provided
Mayo Clinic
Not Provided
Principal Investigator: B. Lawrence Riggs, M.D. Mayo Clinic
Mayo Clinic
January 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP